Join Ian Churcher, SVP Drug Discovery at BenevolentAI for a talk on Artificial Intelligence - From Data to Drugs at the Royal Society of Medicine.
Ian will give an overview of the various ways that AI is being applied to find new uses for existing drugs, as well as finding novel treatments for diseases. We would highlight where progress has been fast and where challenges (for example, data availability) still remain, making subtle / well placed reference to how we are doing this along the way.
He is applying a range of artificial intelligence approaches to all phases of drug discovery and development. Prior to this, for 5 years, he led the Protein Degradation Discovery Performance Unit at GSK, one of the pioneering groups who, working with Prof Craig Crews, demonstrated the application of Protac approaches to drug discovery. Ian has previously held a number of drug discovery & medicinal chemistry roles in GSK and Merck where he has always championed novel technologies and strategies to discover drugs. Ian was also a Visiting Professor in the Department of Chemistry at the University of Oxford from where he also holds MA and D.Phil degrees.